✦ LIBER ✦

Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial

✍ Scribed by Bernard Zinman; Greg Fulcher; Paturi V Rao; Nihal Thomas; Lars A Endahl; Thue Johansen; Rebecka Lindh; Andrew Lewin; Julio Rosenstock; Michel Pinget; Chantal Mathieu

Book ID: 117307866
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 203 KB
Volume: 377
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(10)62305-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin degludec, an ultra-longacting ba

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

✍ Alan J Garber; Allen B King; Stefano Del Prato; Seamus Sreenan; Mustafa K Balci; 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 284 KB

Insulin degludec, an ultra-longacting ba

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

✍ Simon Heller; John Buse; Miles Fisher; Satish Garg; Michel Marre; Ludwig Merker; 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 271 KB

Comparison of insulin lispro protamine s

Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial

✍ V. Koivisto; S. Cleall; A. E. Pontiroli; D. Giugliano 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

Comparison of biphasic insulin aspart 30

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: A 16-week, randomized, open-label, parallel-group trial conducted in russia

✍ Olga Ushakova; Vera Sokolovskaya; Alla Morozova; Farida Valeeva; Olga Zanozina; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 858 KB